Project description:Cymbopogon spp. are grass species widely used around the world as medicinal plants and in various industries for the production of perfumes and pharmaceuticals. Despite their extensive use, there are relatively few studies at the genomic and transcriptomic levels. In this study, transcriptomic data were generated for two species—Cymbopogon flexuosus and Cymbopogon winterianus—to investigate evolutionary aspects and the expression of genes associated with secondary metabolite biosynthesis. The transcriptome assembly revealed a total of 18,286 and 22,458 transcripts for C. flexuosus and C. winterianus, respectively. Furthermore, the reads were mapped against the genomes of related species, including Andropogon gerardii, Sorghum bicolor, Saccharum officinarum, Miscanthus sinensis, Miscanthus lutarioriparius, and Zea mays, to assess their conservation across these genomes. The results indicated which species are more closely related to the Cymbopogon genus and highlighted key differences in metabolic pathways.
Project description:This dataset allows for the exploration of microglial function on gene expression in wild-type and the 5xFAD mouse model of Alzheimer's disease, across multiple brain regions. Mice were treated with the selective CSF1R inhibitor PLX5622, which eliminates >95% of microglia in less than 5 days, from 1.5 to 7 months of age. Thus, these data allow the exploration of the effects, and specificity, of 6 months microglial depletion, in both wild-type and 5xFAD mice.